PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

InnovAge Holding Corp.

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from InnovAge Holding Corp.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Debt Due Cover Ratio: Debt due within a year is covered 25.5 times by its yearly operating cash. Higher than 91% of Healthcare companies in United States.
  • Steadiness Ratio: Sales grew in 3 of the last 3 years; profit grew in 2 of 3. Steadier than 85% of Healthcare companies in United States.

Where $100 of sales goes

$99Operating costs$0.4Interest$0.3Net loss

Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

2.1×

Over the last 3 years its own operating cash covered its investment spending (capex) 2.1 times.

Higher than 74% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

3/3 · 2/3

Sales grew in 3 of the last 3 years; profit grew in 2 of 3.

Steadier than 85% of Healthcare companies in United States.

Growth Efficiency Ratio

$13

Sales grew 44% in 3 years; of every extra $100 of sales, $13 became extra profit.

Lower than 57% of Healthcare companies in United States.

Asset Productivity Ratio

+44% / -2%

In 3 years sales changed by +44% while total assets changed by -2%. Sales grew faster than assets.

Balance-sheet strength

Debt Due Cover Ratio

25.5×

Debt due within a year is covered 25.5 times by its yearly operating cash.

Higher than 91% of Healthcare companies in United States.

Cash Cushion Ratio

+4%

Cash, after subtracting all debt, equals 4% of its market value (net cash).

Lower than 59% of Healthcare companies in United States.

Tangible Assets Ratio

74%

Of every $100 the company owns, $74 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

Less tangible than 59% of Healthcare companies in United States.

Tangible Net Worth Ratio

38%

Of every $100 of net worth, $38 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

Less tangible than 59% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

InnovAge Holding Corp. made a loss over the last year. InnovAge Holding Corp. owes $0.52 for every $1 it owns. InnovAge Holding Corp. made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Jun 2026.

P/E ratio

Loss

InnovAge Holding Corp. made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

5.51

The share price is 5.51 times InnovAge Holding Corp.'s book value per share, higher than 75% of Healthcare companies in United States.

Market cap

$1.3 B

The total market value of all of InnovAge Holding Corp.'s shares at today's price (share price × number of shares), larger than 67% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$236 M

What InnovAge Holding Corp. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$1.73

Net worth divided by the number of shares. The share price of $9.52 is 5.5 times this, which is the P/B above.

Return on equity (ROE)

-0.3%

InnovAge Holding Corp. lost 0.3% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.

Owes vs Owns

0.52×

InnovAge Holding Corp. owes $0.52 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.

Dividend yield

None

InnovAge Holding Corp. does not currently pay a dividend.

Revenue growth

+16%

Revenue rose 16% in the year to Jun 2026, and grew 13% a year on average over 3 years.

Profit growth

Loss

InnovAge Holding Corp. made a loss in each of the last two years.

Profit margin

-0.3%

InnovAge Holding Corp. lost $0 for every $100 of revenue.

Interest cover

1.4×

InnovAge Holding Corp.'s operating profit covered its interest costs 1.4 times in the year to Jun 2026.

Cash vs debt

Net cash

InnovAge Holding Corp. held $54 M more cash than debt (net cash) at Jun 2026.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For InnovAge Holding Corp.: $1.3 B ÷ $236 M (30 Jun 2026) = 5.5.

What is InnovAge Holding Corp.'s return on equity?

InnovAge Holding Corp. lost 0.3% of its shareholders' money over the last year, higher than 75% of Healthcare companies in United States.

How much does InnovAge Holding Corp. owe compared with what it owns?

InnovAge Holding Corp. owes $0.52 for every $1 it owns (moderate), higher than 57% of Healthcare companies in United States.

Does InnovAge Holding Corp. pay a dividend?

No. InnovAge Holding Corp. does not currently pay a dividend.

Is InnovAge Holding Corp.'s revenue growing?

Revenue rose 16% in the year to Jun 2026, and grew 13% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.